Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Vivus, Inc. (VVUS) Starts Presentation at 25th Annual ROTH Conference

Posted on March 19, 2013 by Mission IR

Vivus is a biopharmaceutical company focused on commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health for U.S., Europe and other world markets. The company offers Qsymia, which is in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. For more information, visit the company’s Web site: http://www.vivus.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *